(Q28371947)

2

0 references

J Rose

3

0 references

J Friedrich

4

0 references

W J Suling

5

0 references

J A Maddry

Problems in the management of opportunistic infections in patients infected with human immunodeficiency virus

6

0 references

language of work or name

English

0 references

publication date

30 April 1999

0 references

published in

Carbohydrate Research

0 references

volume

317

0 references

issue

1-4

0 references

page(s)

164-79

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Homologated aza analogs of arabinose as antimycobacterial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Tin(IV) chloride mediated glycosylation in arabinofuranose, galactofuranose and rhamnopyranose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Structure-activity studies leading to ethambutol, a new type of antituberculous compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Ethambutol potentiates extracellular and intracellular activities of clarithromycin, sparfloxacin, amikacin, and rifampin againstMycobacterium avium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

5'-Azido and 5'-fluoro alpha-nucleosides as analogues of AZT and FLT.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Synthesis of a trehalose homolog, 6-deoxy-alpha-D-gluco-heptopyranosyl 6-deoxy-alpha-D-gluco-heptopyranoside, and the corresponding bis(heptosiduronic acid).

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2899%2900069-5